With increasing demand for personalized medicines, the metabolomics market is growing along with massive investments by public & private sectors in this field. Also, the market is driven by the introduction of new technology-based metabolomics to fulfil the demand for accurate diagnosis of different diseases.
@Get Free Sample Report at https://www.wiseguyreports.com/sample-request/3792268-metabolomics-market-2018-2025
The market is segmented by applications into biomarker & drug discovery, nutrigenomics, toxicology testing, personalized medicine, and others. The biomarker & drug discovery segment holds the largest share of the global metabolomics market due to development in efficiency metabolic profiling of biomarkers and rising prevalence of chronic diseases such as cancer, CVD, and diabetes. In 2016, the biomarker market in the U.S. was valued at around 3.9 billion dollars in the area of oncology.
Also, the accuracy and diagnostic properties of biomarkers for cancer diagnostic tests are boosting the growth of the market. The personalized medicine segment is growing at the highest rate due to several partnerships between pharmaceutical companies and biotechnology firms for biomarker and drug discovery.
By Product & Services
o Liquid Chromatography
o Gas Chromatography
o Capillary Electrophoresis
o Nuclear Magnetic Resonance Spectroscopy
o Mass Spectrometry
Geographically, the market is segmented by North America, South America, Europe, Asia-Pacific, and RoW. North America is dominating the global metabolomics market due to rising awareness towards metabolomics, the flow in demand for personalized medicines, and the increasing R&D activities in the field of metabolomics in the region. The Asia-Pacific region is growing at the highest growth rate due to the refining of pharmaceutical research techniques with growing economies in developing countries.
The major players in the Metabolomics market are Bio-Rad Laboratories, Metabolon, Agilent Technologies Inc., Bruker Corporation, Human Metabolome Technologies Inc., LECO Corporation, Shimadzu Corporation, Thermo Fisher Scientific Inc., and Waters Corporation, among others.
Some of the key recent developments in the Metabolomics market are:
The report covers the factors impacting the market, Porter 5 Forces, Market Share Analysis, Price trend analysis, Product Benchmarking, and company profiles.
Why purchase the report?
@Get Detailed Report at https://www.wiseguyreports.com/reports/3792268-metabolomics-market-2018-2025
Table of Contents
Chapter 1. Methodology and Scope
1.1 Research methodology
1.2 Scope of the Report
Chapter 2 Executive Summary
Chapter 3. Industry Analysis
3.1 Market Drivers
3.2 Market Restraints
3.3 Porters Five Forces Analysis
3.3.1 Suppliers Power
3.3.2 Buyer Power
3.3.3 Industry Competition
3.3.4 Threat of new Entrant
3.3.5 Threat of Substitutes
Chapter 7 Geographic Analysis
7.1. Asia Pacific
7.3.5. Rest of Asia Pacific
7.2.6. Rest of Europe
7.3. North America
7.3.4. Rest of North America
7.4. South America
7.4.3. Rest of South America
Chapter 8. Competitive Landscape
8.1 Market Player Analysis
8.2 Company Benchmarking
8.3 Key Strategies Adopted by Major Companies
Chapter 9 Company Profiles*
9.1 Thermo Fisher Scientific Inc.
9.2 Bio-Rad Laboratories
9.3 Agilent Technologies Inc.
9.4 Danaher Corporation
9.5 Waters Corporation
9.6 Bruker Corporation
9.7 Human Metabolome Technologies, Inc.
9.8 Metabolon Inc.
9.9 LECO Corporation
9.10 Shimadzu Corporation
Chapter 10 Global Metabolomics Market – Appendix
*Note: Additional company profiles will be included on request
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.